CAMBRIDGE, Mass. (AP) 鈥� CAMBRIDGE, Mass. (AP) 鈥� Cullinan Therapeutics, Inc. (CGEM) on Thursday reported a loss of $53.7 million in its second quarter.
The Cambridge, Massachusetts-based company said it had a loss of 81 cents per share.
The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 71 cents per share.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/CGEM
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
